| Issue |
BioMedicine
Volume 9, Number 4, December 2019
|
|
|---|---|---|
| Article Number | 26 | |
| Number of page(s) | 6 | |
| DOI | https://doi.org/10.1051/bmdcn/2019090426 | |
| Published online | 14 November 2019 | |
Original article
Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
1
Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2
Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
3
Dermatology Unit, Department of Translational Medicine, University of Eastern Piedmont Amedeo Avogadro, 28100 Novara, Italy
4
Deparment of Biostatistics, Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
5
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
* Corresponding author. Medical Biology Research Center, Kermanshah University of Medical Sciences, Beheshti Blvd, Kermanshah, Kermanshah Province, Iran. E-mail address: sadeghi_mbrc@yahoo.com (M. Sadeghi).
Received:
25
April
2019
Accepted:
13
August
2019
Background: Psoriasis is the prime example of psoriasiform tissue pattern and should be differentiated from other psoriasiform dermatoses both clinically and histopathologically.
Aim: To evaluate immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis for diagnostic purposes.
Methods: An analytical cross-sectional study was performed on the paraffin blocks of 60 psoriasis and 31 psoriasiform dermatitis patients between 2014 and 2017. The selected formalin-fixed paraffin-embedded tissues from each biopsy specimen were cut into 4-micron sections. Initial sections were stained by hematoxylin and eosin staining. Primary antihuman antibodies against P53, Ki-67, and CD34 were applied. Positive control samples for biomarkers were received from former strongly positive samples of papillary endothelial hyperplasia, high grade lymphoma, and breast ductal carcinoma for CD34, Ki-67, and P53, respectively.
Results: Out of 60 psoriasis patients, 56.7% were men, with the mean age of 36.8 years. From 31 psoriasiform patients, 45.2% were men, with the mean age of 37.5 years. Both groups were matched in terms of sex and age. The mean staining of three markers was more significant in psoriasiform dermatitis than psoriasis.
Conclusion: In spite of some other researches, the present study showed expression of P53, Ki-67, and CD34 biomarkers were significantly higher in psoriasiform dermatitis than psoriasis.
Key words: Immunohistochemistry / Psoriasis / Dermatitis
© Author(s) 2019. This article is published with open access by China Medical University
Open Access This article is distributed under terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided original author(s) and source are credited.